IPO registrations (S-1, F-1) · Registrants
XORTX Therapeutics Inc.
- SEC CIK
- 1729214 · filings on EDGAR ↗
- Registration
- Form F-1, first filed 2021-08-12, last 2026-02-13; 4 initial registrations, 6 amendments
- Outcome
- Final prospectus filed 2021-10-14; declared effective 2021-10-12
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- A1
- Business address
- SUITE 2400 - 745 THURLOW STREET, Vancouver, A1 V6E 0C5
- Ticker
- XRTX (Nasdaq)
- EDGAR entity type
- other
- Insiders and CEO pay
- XORTX Therapeutics Inc. on the corporate pages
Offering terms
- Final price
- $4.13 per share (424B4 filed 2021-10-14, an initial public offering)
- Shares sold
- 2,906,000
- Gross proceeds
- $12,001,780 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol XRX
- Lead underwriters
- A.G.P./Alliance Global Partners
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Form D issuer: XORTX Therapeutics Inc. EXACT (CIK (EXACT))
- SEC filer: XORTX THERAPEUTICS INC. EXACT (CIK (EXACT))
Filings 22
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2021-08-12 | F-1 | F-1 (foreign registration) | XORTX Therapeutics Inc. | 0001753926-21-000333 ↗ |
| 2021-09-16 | F-1/A | F-1/A (amendment) | XORTX Therapeutics Inc. | 0001753926-21-000445 ↗ |
| 2021-10-04 | F-1/A | F-1/A (amendment) | XORTX Therapeutics Inc. | 0001753926-21-000527 ↗ |
| 2021-10-12 | F-1/A | F-1/A (amendment) | XORTX Therapeutics Inc. | 0001753926-21-000563 ↗ |
| 2021-10-12 | EFFECT | EFFECT (declared effective) | XORTX Therapeutics Inc. | 9999999995-21-003848 ↗ |
| 2021-10-14 | 424B4 | 424B4 (final prospectus) | XORTX Therapeutics Inc. | 0001753926-21-000570 ↗ |
| 2022-09-08 | F-1 | F-1 (foreign registration) | XORTX Therapeutics Inc. | 0001104659-22-098458 ↗ |
| 2022-09-12 | F-1/A | F-1/A (amendment) | XORTX Therapeutics Inc. | 0001104659-22-099008 ↗ |
| 2022-09-21 | F-1/A | F-1/A (amendment) | XORTX Therapeutics Inc. | 0001104659-22-101944 ↗ |
| 2022-09-22 | EFFECT | EFFECT (declared effective) | XORTX Therapeutics Inc. | 9999999995-22-002801 ↗ |
| 2022-09-30 | EFFECT | EFFECT (declared effective) | XORTX Therapeutics Inc. | 9999999995-22-002885 ↗ |
| 2022-10-05 | 424B4 | 424B4 (final prospectus) | XORTX Therapeutics Inc. | 0001104659-22-106406 ↗ |
| 2023-02-03 | EFFECT | EFFECT (declared effective) | XORTX Therapeutics Inc. | 9999999995-23-000280 ↗ |
| 2023-08-07 | EFFECT | EFFECT (declared effective) | XORTX Therapeutics Inc. | 9999999995-23-002289 ↗ |
| 2023-08-07 | EFFECT | EFFECT (declared effective) | XORTX Therapeutics Inc. | 9999999995-23-002292 ↗ |
| 2024-11-15 | F-1 | F-1 (foreign registration) | XORTX Therapeutics Inc. | 0001104659-24-119763 ↗ |
| 2024-11-25 | EFFECT | EFFECT (declared effective) | XORTX Therapeutics Inc. | 9999999995-24-003574 ↗ |
| 2025-09-25 | F-1 | F-1 (foreign registration) | XORTX Therapeutics Inc. | 0001104659-25-093362 ↗ |
| 2026-02-13 | F-1/A | F-1/A (amendment) | XORTX Therapeutics Inc. | 0001104659-26-014489 ↗ |
| 2026-02-17 | EFFECT | EFFECT (declared effective) | XORTX Therapeutics Inc. | 9999999995-26-000597 ↗ |
| 2026-05-13 | EFFECT | EFFECT (declared effective) | XORTX Therapeutics Inc. | 9999999995-26-001604 ↗ |
| 2026-05-15 | 424B4 | 424B4 (final prospectus) | XORTX Therapeutics Inc. | 0001104659-26-062030 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2021-10-12 | F-1/A | registration statement | $1.64 | - | - | 0 | primary document; price sentence | document ↗ | ||
| 2021-10-14 | 424B4 | final prospectus | $4.13 | 2,906,000 | $12,001,780 | Nasdaq XRX | 1 | primary document; price sentence, shares headline, proceeds table, cover names 1 | document ↗ |
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2024-10-31 | XORTX Therapeutics Inc. | Other | $1,767,566 | $0 | 1 | 1 |
| 2018-01-25 | XORTX Therapeutics Inc. | Other | $505,283 | $505,283 | 1 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Form D issuer | XORTX Therapeutics Inc. | Form D private offerings | CIK (EXACT) | |
| SEC filer | XORTX THERAPEUTICS INC. | SEC filers (EDGAR) | CIK (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, A1 first:
- ONCOGENEX TECHNOLOGIES INC A1
- Aspreva Pharmaceuticals CORP A1
- Lexaria Bioscience Corp. A1
- Zymeworks BC Inc. A1
- BetterLife Pharma Inc. A1
- ABATTIS BIOCEUTICALS CORP A1
- BriaCell Therapeutics Corp. A1
- Old API Wind-down Ltd. A1
- AbCellera Biologics Inc. A1
- BODY & MIND INC. A1
In other datasets, the same topic (Health) in A1:
- Form D issuer: 1219014 B.C. Ltd. (Form D private offerings)
Interests: Pharmaceutical Preparations · Health